Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Fetal Tissue, Stem Cells & Bioethics

Fetal Tissue, Stem Cells & Bioethics

137 results

Filter Results By

Filter Applied. Clear All
Reset All Filters
137 results
featured-image
Fetal Tissue, Stem Cells & Bioethics

Faith-Based Charities Serving Vulnerable Children Should Not Be Required to Facilitate Abortion

Federal regulations issued by the Obama Administration have raised concerns that Christian charities operating federally funded care provider facilities housing unaccompanied alien children could be required to facilitate access to abortion.

Thomas M. Messner, J.D.
March 12, 2015
Please login to bookmark Close
featured-image
Fetal Tissue, Stem Cells & Bioethics

Holding, Listening, Rocking – and a Blessing in Turn

featured-image
Fetal Tissue, Stem Cells & Bioethics

Brave New Britain: The U.K. Approves Production of Three-Parent Embryos

The concept of “designer babies” may sound like science fiction, a literal Brave New World, but it is decidedly not fictional –  it is here now and being pushed rapidly into fertility clinics. After only a brief debate today in the House of Commons, British Members of Parliament (MPs) approved a proposal to create genetically-engineered babies who contain the DNA of three parents.

featured-image
Fetal Tissue, Stem Cells & Bioethics

The Continuing Promise of Non-Embryonic Stem Cells

featured-image
Fetal Tissue, Stem Cells & Bioethics

Scientific Advances in Stem Cell Research Continue to Make Use of Embryos Outdated and Unnecessary

Diabetes has long been one of the main diseases for which human embryonic stem cell (embryo-destroying) research, or hESCR, was claimed to hold the greatest promise of curing. But for well over a decade now, ethically contentious human embryonic stem cell research (hESCR) has notably failed to live up to all its hype, with promises of miracle cures within “five to 10 years” remaining unfulfilled.

featured-image
Fetal Tissue, Stem Cells & Bioethics

The United Kingdom’s Rubicon on Three-Parent Embryos

Later this month, leading scientists from around the world are set to caution a UK parliamentary inquiry against the creation of babies using the genetic material of three parents.  On October 22, this group will warn the inquiry against such genetic engineering and the possible scientific and ethical problems it could bring.

featured-image
Fetal Tissue, Stem Cells & Bioethics

Ethical Stem Cells Provide Model for Progress in Down Syndrome Research

Researchers using ethically uncontroversial induced pluripotent stem cells (iPSCs) have achieved what appears to be a major breakthrough in understanding the origin and development of Down syndrome, according to a new study recently published in Nature Communications.

featured-image
Fetal Tissue, Stem Cells & Bioethics

Thailand Moves to Reform Law following Surrogacy Cases Gone Awry

Last week, Thailand officials announced a reform of its surrogacy legislation by way of a newly drafted bill that would ban commercial surrogacy.

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image